Evaluation of the Pupil Dilation Reflex in Response to Noxious Stimulation in Anaesthetized Children. A Proof of Concept Trial (Pain@OR-kids)
Primary Purpose
Pain, Monitoring, Intraoperative
Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
PDR measurement
Sponsored by
About this trial
This is an interventional diagnostic trial for Pain
Eligibility Criteria
Inclusion Criteria:
- Scheduled abdominal, urological or otorhinolaryngology surgery under general anaesthesia
- ASA I-II
Exclusion Criteria:
- History of eye deformity, invasive ophthalmologic surgery
- Known cranial nerve(s) deficit
- Infection of the eye
- Predicted difficult airway management (Paediatric Difficult Airway Guidelines - Difficult Airway Society)
- Chronic opioid use (>3 months)
- Ongoing treatment with beta-blockers, dopamine antagonists, topical atropine
- Preoperatively administrated benzodiazepins or antiemetics
Sites / Locations
- University hospital Antwerp
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Experimental
Arm Label
PDR measurement group A
PDR measurement group B
PDR measurement group C
Arm Description
Two measurements of PDR perioperatively before and after opioid administration in toddlers (28 days until 23 months)
Two measurements of PDR perioperatively before and after opioid administration in children (2 until 11 years)
Two measurements of PDR perioperatively before and after opioid administration in adolescents (12 until 18 years)
Outcomes
Primary Outcome Measures
Stimulation Intensity
Necessary stimulation intensity to dilate the pupil more than 13%
Secondary Outcome Measures
Pupillary Pain Index score
Device specific PPI score defined in accordance to stimulation intensity necessary for pupil dilation more than 13%
Blood pressure
Hypertension as a common used parameter for perioperative nociceptive assessment defined as an increase in systolic blood pressure by >10% of the initial systolic blood pressure
Heart rate
Tachycardia as a common used parameter for perioperative nociceptive assessment
Full Information
NCT ID
NCT03449732
First Posted
February 22, 2018
Last Updated
May 17, 2022
Sponsor
University Hospital, Antwerp
1. Study Identification
Unique Protocol Identification Number
NCT03449732
Brief Title
Evaluation of the Pupil Dilation Reflex in Response to Noxious Stimulation in Anaesthetized Children. A Proof of Concept Trial
Acronym
Pain@OR-kids
Official Title
Evaluation of the Pupil Dilation Reflex (PDR) Using a Pupillary Pain Index (PPI) Stimulation Protocol in Response to Noxious Stimulation in Anaesthetized Children. A Proof of Concept Trial
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Completed
Study Start Date
March 30, 2018 (Actual)
Primary Completion Date
April 26, 2021 (Actual)
Study Completion Date
December 31, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Antwerp
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
After conduction a pilot study, pupillary dilation reflex (PDR) is measured in response to nociceptive stimulation perioperatively in infants, children and adolescents.
Detailed Description
An infrared camera of the video pupillometer measures the pupillary dilation reflex (PDR) in response to incremental nociceptive stimuli. The PDR is a robust reflex, even in patients under general anesthesia, and may provide a potential evaluation of the autonomous nociceptive circuit. American Society of Anesthesiologists (ASA) classification I or II patients from the age of 28 days till 18 years undergoing elective surgery under general anesthesia are recruited. Enrolled patients perioperative undergo PDR measurement at 2 different standardized times (before and after opioid administration) generated by an inbuilt pupillary pain index (PPI) protocol. PPI, as a surrogate for nociception includes noxious stimulations from 10 up to 60 milli ampere (mA) until pupil dilation is larger than 13% from baseline diameter. Therefore, no inappropriate high stimulation is executed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Monitoring, Intraoperative
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PDR measurement group A
Arm Type
Experimental
Arm Description
Two measurements of PDR perioperatively before and after opioid administration in toddlers (28 days until 23 months)
Arm Title
PDR measurement group B
Arm Type
Experimental
Arm Description
Two measurements of PDR perioperatively before and after opioid administration in children (2 until 11 years)
Arm Title
PDR measurement group C
Arm Type
Experimental
Arm Description
Two measurements of PDR perioperatively before and after opioid administration in adolescents (12 until 18 years)
Intervention Type
Device
Intervention Name(s)
PDR measurement
Other Intervention Name(s)
PPI assessment
Intervention Description
PDR measurement at two standardized times perioperatively:
Anesthetized subject by sevoflurane sedation until a minimum alveolar concentration (MAC) of at least 1,5 is reached
Administration of fentanyl 2µg/kg, in the absence of adjustments in sedation depth
Primary Outcome Measure Information:
Title
Stimulation Intensity
Description
Necessary stimulation intensity to dilate the pupil more than 13%
Time Frame
During pupil measurements in the perioperative period
Secondary Outcome Measure Information:
Title
Pupillary Pain Index score
Description
Device specific PPI score defined in accordance to stimulation intensity necessary for pupil dilation more than 13%
Time Frame
During pupil measurements in the perioperative period
Title
Blood pressure
Description
Hypertension as a common used parameter for perioperative nociceptive assessment defined as an increase in systolic blood pressure by >10% of the initial systolic blood pressure
Time Frame
During PDR measurements
Title
Heart rate
Description
Tachycardia as a common used parameter for perioperative nociceptive assessment
Time Frame
During PDR measurements
10. Eligibility
Sex
All
Minimum Age & Unit of Time
28 Days
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Scheduled abdominal, urological or otorhinolaryngology surgery under general anaesthesia
ASA I-II
Exclusion Criteria:
History of eye deformity, invasive ophthalmologic surgery
Known cranial nerve(s) deficit
Infection of the eye
Predicted difficult airway management (Paediatric Difficult Airway Guidelines - Difficult Airway Society)
Chronic opioid use (>3 months)
Ongoing treatment with beta-blockers, dopamine antagonists, topical atropine
Preoperatively administrated benzodiazepins or antiemetics
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nathalie Kegels, MD
Organizational Affiliation
University Hospital, Antwerp
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Vera Saldien, MD
Organizational Affiliation
University Hospital, Antwerp
Official's Role
Study Chair
Facility Information:
Facility Name
University hospital Antwerp
City
Edegem
State/Province
Antwerp
ZIP/Postal Code
2650
Country
Belgium
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Evaluation of the Pupil Dilation Reflex in Response to Noxious Stimulation in Anaesthetized Children. A Proof of Concept Trial
We'll reach out to this number within 24 hrs